ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Institut universitaire de cardiologie et de pneumologie de Québec at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Institut universitaire de cardiologie et de pneumologie de Québec brings 5 presentations from 2 research groups to ASHG 2026 in Montréal. Its program centres on cardiovascular genetics, heart-valve disease and cardiometabolic drivers of steatotic liver disease. Mathieu Lab brings single-cell CRISPRi screens of targets promoting heart-valve fibrosis, while Arsenault Lab brings an integrated proteogenomic study of molecular drivers in the human liver.

OrganizationASHG 2026 Attendance
4 PhD Students
Mathieu Labpatrickmathieulab.ca
Wet + dry lab~6 people
Studies cardiovascular disease using chromatin immunoprecipitation, reporter assays and QTL data. Focuses on vascular atheroma and heart-valve fibrocalcification.
38 papers since 2024
›
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression
JAMA Cardiology, 2024
Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation
Nature Communications, 2024
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk
European Heart Journal, 2024
Source: OpenAlex author A5071026604
Funded by Canadian Institutes of Health Research (CIHR), Fonds de recherche du Québec (FRQS) +1 more
›
Canadian Institutes of Health Research (CIHR), Molecular and Genetic Epidemiology to Understand Mitral Valve Prolapse · active
Canada's federal health-research funder, the equivalent of the NIH.
“[name] receives $1,025,100 over 5 years for his project Molecular and Genetic Epidemiology to Understand Mitral Valve Prolapse.”
Fonds de recherche du Québec (FRQS), Fellowship and research grant · 2024-2025
“awarded a fellowship and a research grant from the Fonds de recherche du Québec (FRQS) 2024-2025”
Fondation IUCPQ, Jean-G.-Dumesnil scholarship
“one-year $16,000 Jean-G.-Dumesnil scholarship, awarded by the Direction de la recherche universitaire in collaboration with the Fondation IUCPQ”
Source: lab pages
11 platforms and techniques
›
Works with
DNA-binding assays, Reporter assays, Chromatin immunoprecipitation, Single-cell RNA-sequencing, Single-nucleus RNA-sequencing
Techniques
Functional genomics, Machine-learning algorithms, Mendelian randomization, Phenome-wide association analyses, Primary culture of human cardiac cells, 3D genome organization assays
Source: lab pages
Currently hiring
›
“Doctoral/post-doctoral position: The project involves both bioinformatics and molecular biology analyses.”
Source: lab positions page
Talk
Wed Oct 21
2:15 pm
Single-cell CRISPRi screens identify targets and gene programs promoting heart valve fibrosis
Collaborators: Université Laval
DifferentiationRegulation of transcriptionGenome editing/CRISPRSingle-cell
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Single-cell CRISPRi screens identify targets and gene programs promoting heart valve fibrosis
Collaborators: Université Laval
DifferentiationGenome editing/CRISPRNon-coding RNARegulation of transcription
Arsenault Labresearchgate.net/profile/lab/Benoit-Arsenault-Lab
Dry lab~8 people
Studies cardiometabolic biomarkers using molecular epidemiology, genomics, proteomics and metabolomics. Targets obesity, fatty liver and valve disease prevention.
46 papers since 2024
›
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression
JAMA Cardiology, 2024
Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation
Nature Communications, 2024
Mendelian Randomization Applied to Neurology
Neurology, 2024
Source: OpenAlex author A5070728487
Funded by Fonds de recherche du Québec - Santé, Instituts de recherche en santé du Canada +4 more
›
Université Laval - Fonds internes; Fonds de recherche du Québec - Santé, Réseaux thématiques de recherche · 2024-2032
“Réseau thématique de recherche FRQS en santé cardiométabolique, diabète et obésité (CMDO U. Laval 2024-2032)”
Instituts de recherche en santé du Canada, Subvention Projet · 2025-2029
“Subvention Projet; Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada; Du 1 avril 2025 au 31 mars 2029”
Instituts de recherche en santé du Canada, Subvention Projet · 2024-2029
“Subvention Projet; Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada; Du 1 avril 2024 au 31 mars 2029”
+3 more on the lab page
Source: lab pages
5 platforms and techniques
›
Techniques
Molecular epidemiology, Mendelian randomization, Pharmacogenomics, Transcriptome-wide association studies, Proteome-wide association studies
Source: lab pages
No openings posted
Poster
Wed Oct 21
2:30 pm
An integrated proteogenomic investigation of the human liver uncovers molecular drivers of steatotic liver disease
Collaborators: Université Laval
Multi-omicsMendelian randomizationProteomicsMetabolic disorder
2 more presenters — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Institut universitaire de cardiologie et de pneumologie de Québec

Tell us what you sell and we’ll find the people at Institut universitaire de cardiologie et de pneumologie de Québec most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction